Forward Citations = 55

Loading Chart...

3 inventors (with patents filed for the assignee):

Francis Lepage (4 out of 5 patents)

Bernard M Hublot (4 out of 19 patents)

Jacques N Astoin (1 out of 5 patents)

4 patents: Sort by Forward Citations

1. 5464860 - N(pyrazol-3-yl) benzamides and pharmaceutical compositions (1995-11-07),

2. 5258397 - 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure (1993-11-02),

3. 5059614 - Novel isoxazole and isoxazoline compounds with anticonvulsant activity (1991-10-22),

4. 4745125 - Antiulcer benzimidazoles (1988-05-17),

Company Overview

Novapharme is a pharmaceutical company specializing in the development and distribution of high-quality generic medications. With a focus on innovation and customer satisfaction, Novapharme is dedicated to improving access to affordable healthcare solutions worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#640 in Paris

#3,354 in France

Paris, France

Novapharme

Forward Citations = 55

3 inventors:

Francis Lepage (4 out of 5 patents)

Bernard M Hublot (4 out of 19 patents)

Jacques N Astoin (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novapharme. Retrieved from https://idiyas.com/company/novapharme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]